Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.93 EUR
−38.03 M EUR
6.13 M EUR
14.17 M
About LAVA Therapeutics N.V.
Sector
Industry
CEO
Stephen Allen Hurly
Website
Headquarters
Utrecht
Founded
2016
ISIN
NL0015000AG6
FIGI
BBG00ZVJM751
LAVA Therapeutics NV is an immuno-oncology company, which engages in the proprietary Gammabody platform to develop a portfolio of bispecific gamma delta T cell engagers for the potential treatment of solid tumors and hematological malignancies. The company was founded by Erik van den Berg in 2016 and is headquartered in Utrecht, the Netherlands.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 4PKB is 0.89 EUR — it has decreased by −1.09% in the past 24 hours. Watch LAVA THERAPEUTICS N.V. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange LAVA THERAPEUTICS N.V. stocks are traded under the ticker 4PKB.
4PKB stock has risen by 1.12% compared to the previous week, the month change is a −6.70% fall, over the last year LAVA THERAPEUTICS N.V. has showed a −55.08% decrease.
We've gathered analysts' opinions on LAVA THERAPEUTICS N.V. future price: according to them, 4PKB price has a max estimate of 2.92 EUR and a min estimate of 1.95 EUR. Watch 4PKB chart and read a more detailed LAVA THERAPEUTICS N.V. stock forecast: see what analysts think of LAVA THERAPEUTICS N.V. and suggest that you do with its stocks.
4PKB reached its all-time high on Apr 7, 2021 with the price of 13.52 EUR, and its all-time low was 0.89 EUR and was reached on Jan 23, 2025. View more price dynamics on 4PKB chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4PKB stock is 2.26% volatile and has beta coefficient of 1.36. Track LAVA THERAPEUTICS N.V. stock price on the chart and check out the list of the most volatile stocks — is LAVA THERAPEUTICS N.V. there?
Today LAVA THERAPEUTICS N.V. has the market capitalization of 23.81 M, it has decreased by −7.47% over the last week.
Yes, you can track LAVA THERAPEUTICS N.V. financials in yearly and quarterly reports right on TradingView.
LAVA THERAPEUTICS N.V. is going to release the next earnings report on Mar 20, 2025. Keep track of upcoming events with our Earnings Calendar.
4PKB earnings for the last quarter are −0.41 EUR per share, whereas the estimation was −0.30 EUR resulting in a −39.39% surprise. The estimated earnings for the next quarter are −0.28 EUR per share. See more details about LAVA THERAPEUTICS N.V. earnings.
LAVA THERAPEUTICS N.V. revenue for the last quarter amounts to 0.00 EUR, despite the estimated figure of 0.00 EUR. In the next quarter, revenue is expected to reach 2.41 M EUR.
4PKB net income for the last quarter is −11.04 M EUR, while the quarter before that showed −7.75 M EUR of net income which accounts for −42.59% change. Track more LAVA THERAPEUTICS N.V. financial stats to get the full picture.
No, 4PKB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jan 27, 2025, the company has 37.00 employees. See our rating of the largest employees — is LAVA THERAPEUTICS N.V. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LAVA THERAPEUTICS N.V. EBITDA is −24.25 M EUR, and current EBITDA margin is −620.11%. See more stats in LAVA THERAPEUTICS N.V. financial statements.
Like other stocks, 4PKB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LAVA THERAPEUTICS N.V. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LAVA THERAPEUTICS N.V. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LAVA THERAPEUTICS N.V. stock shows the sell signal. See more of LAVA THERAPEUTICS N.V. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.